Last reviewed · How we verify
diabetic peripheral neuropathic pain
Approved treatments
Clinical guidelines
- FDA label — 1L
Duloxetine is indicated for the treatment of diabetic peripheral neuropathic pain in adults.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- diabetic peripheral neuropathic pain patent landscape — cliff calendar, originator estates, attackable patents
- diabetic peripheral neuropathic pain treatment landscape brief
- diabetic peripheral neuropathic pain treatment updates RSS
Frequently asked questions about diabetic peripheral neuropathic pain
What are the treatment guidelines for diabetic peripheral neuropathic pain?
FDA label publishes guidelines for diabetic peripheral neuropathic pain. 1 guideline references tracked.
Related
- Treatment landscape: diabetic peripheral neuropathic pain patent cliff · diabetic peripheral neuropathic pain CI report
- All diseases: Browse the disease index · Disease landscape hub